Manning & Napier Advisors LLC Astrazeneca PLC Transaction History
Manning & Napier Advisors LLC
- $8.1 Trillion
- Q1 2025
A detailed history of Manning & Napier Advisors LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Manning & Napier Advisors LLC holds 3,055,228 shares of AZN stock, worth $220 Million. This represents 2.77% of its overall portfolio holdings.
Number of Shares
3,055,228
Previous 3,745,531
18.43%
Holding current value
$220 Million
Previous $245 Billion
8.5%
% of portfolio
2.77%
Previous 2.8%
Shares
4 transactions
Others Institutions Holding AZN
# of Institutions
1,386Shares Held
473MCall Options Held
6.08MPut Options Held
4.44M-
Price T Rowe Associates Inc Baltimore, MD60.4MShares$4.35 Billion0.46% of portfolio
-
Primecap Management CO Pasadena, CA41MShares$2.96 Billion2.12% of portfolio
-
Capital International Investors Los Angeles, CA37.5MShares$2.7 Billion0.48% of portfolio
-
Bank Of America Corp Charlotte, NC24MShares$1.73 Billion0.13% of portfolio
-
Franklin Resources Inc San Mateo, CA19.5MShares$1.4 Billion0.37% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $223B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...